XML 17 R7.htm IDEA: XBRL DOCUMENT v3.23.3
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
6 Months Ended
Aug. 31, 2023
Aug. 31, 2022
Cash provided (used) by operating activities:    
Net income $ 49,962 $ 55,267
Adjustments to reconcile net income to net cash provided (used) by operating activities:    
Depreciation and amortization 24,606 21,617
Amortization of financing costs 616 512
Non-cash operating lease expense 3,941 5,186
Provision for credit losses 3,671 963
Non-cash share-based compensation 16,526 24,114
Gain on sale of Personal Care business 0 (1,336)
Gain on the sale or disposal of property and equipment (246) (20)
Deferred income taxes and tax credits 6,845 3,977
Changes in operating capital, net of effects of acquisitions of businesses:    
Receivables (14,427) (46,754)
Inventory 19,804 (77,348)
Prepaid expenses and other current assets (5,391) 575
Other assets and liabilities, net (253) (2,040)
Accounts payable 71,990 3,333
Accrued expenses and other current liabilities (10,317) (43,767)
Accrued income taxes (9,595) (19,731)
Net cash provided (used) by operating activities 157,732 (75,452)
Cash used by investing activities:    
Capital and intangible asset expenditures (20,557) (112,635)
Net payments to acquire businesses, net of cash acquired 0 (148,111)
Proceeds from sale of Personal Care business 0 1,804
Proceeds from the sale of property and equipment 246 20
Net cash used by investing activities (20,311) (258,922)
Cash (used) provided by financing activities:    
Proceeds from revolving loans 261,150 573,500
Repayment of revolving loans (348,150) (465,000)
Proceeds from term loans 0 250,000
Repayment of long-term debt (3,125) (1,900)
Payment of financing costs 0 (586)
Proceeds from share issuances under share-based compensation plans 2,380 2,934
Payments for repurchases of common stock (54,535) (18,305)
Net cash (used) provided by financing activities (142,280) 340,643
Net (decrease) increase in cash and cash equivalents (4,859) 6,269
Cash and cash equivalents, beginning balance 29,073 33,381
Cash and cash equivalents, ending balance 24,214 39,650
Supplemental non-cash investing activity:    
Capital expenditures included in accounts payable $ 2,790 $ 8,484